Finzati - Logo
MCK logo

McKesson Corporation

MCK • Medical - Distribution
$1030.12
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$122.79B
Growth
10.4%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 17.1%Positive free cash flow · 46.27Consistent free cash flow · 5/5Weak liquidity · 0.85
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:09 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1,030.12
Change0.00%
Shares Out119.20M
Market Cap$122.79B
Enterprise Value$127.36B
52W Range637.00 - 999.00
Beta0.32
P/E26.74
P/S0.30
P/B-28.96
P/FCF18.20
EV/Sales0.31

Investment DNA

How strong this company looks for long-term investors

69
out of 100
Business Quality
Margins, moat, returns
40/100
Financial Strength
Debt, cash, stability
47/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
73/100
Why this score▼
Positive revenue growth · 17.1%Positive free cash flow · 46.27Consistent free cash flow · 5/5Weak liquidity · 0.85

Analyst view

Analyst sentiment and price target

MCK
Analyst sentiment
Based on 31 analyst votes · 2026-10-20
90/100
Bullish
Bullish
25
Hold
6
Bearish
0
Price Target
2026-08-07
Low
$875.00
Mean
$1007.50
Median
$1032.50
High
$1085.00

Company Overview

IPO: 11/10/1994
Industry: Medical - Distribution
P/B i: -28.96
Debt / Equity i: -3.97
Operating Margin: 1.60%
Net Margin: 1.18%
ROE i: -
ROIC: -

Financial Health

Score9 / 20
Debt / Equity: -3.97
Current Ratio: 0.85
Quick Ratio: 0.49
Status: Moderate

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Dunsire Deborah
Transaction: 07/22/2026
BUY
Change
+277
Price
Not reported
Filing
07/23/2026
Type
BUY
OZAN KEVIN M
Transaction: 07/22/2026
BUY
Change
+277
Price
Not reported
Filing
07/23/2026
Type
BUY
Martinez Maria
Transaction: 07/22/2026
BUY
Change
+277
Price
$814.04
Filing
07/23/2026
Type
BUY